Inclusion Body Hepatitis (IBH) and Newcastle Disease Virus (NDV) Inactivated Vaccine
Formulation:
Emulsion for injection.
Composition:
Each 0.5 ml dose contains:
• Inactivated antigen of FADV 2 (D) ≥ 5 log2 VN¹ units or Equivalent ELISA² unit.
• Inactivated antigen of FADV 8a (E) ≥ 5 log2 VN¹ units or Equivalent ELISA2 unit.
• Inactivated antigen of FADV 8b (E) ≥ 6 log2 VN¹ units or Equivalent ELISA² unit.
• Inactivated antigen of FADV 11 (D) ≥ 6 log2 VN¹ units or Equivalent ELISA² unit.
• Inactivated antigen of NDV-G II (La Sota) and NDV-G VII.1.1 (RYD) ≥ 50 PD₅₀*
The concentrations are expressed by the antibody titer obtained during the potency test. One unit (U) corresponding to an antibody titer of 1.
¹VN: Virus neutralization.
²ELISA: Enzyme-linked Immunosorbent Assay.
* PD₅₀: Protective dose in 50% of the tested chicken.
Indication:
Immunization of breeder and layer chickens for reduction of eggs drop caused by Inclusion Body Hepatitis (IBH) and Newcastle Disease virus (NDV).
Onset of immunity: Three weeks post vaccination.
Duration of immunity: one laying period.
Pack sizes:
250 ml and 500 ml